These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21918019)

  • 1. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.
    Adams-Haduch JM; Onuoha EO; Bogdanovich T; Tian GB; Marschall J; Urban CM; Spellberg BJ; Rhee D; Halstead DC; Pasculle AW; Doi Y
    J Clin Microbiol; 2011 Nov; 49(11):3849-54. PubMed ID: 21918019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.
    Ahmed SS; Alp E; Ulu-Kilic A; Dinc G; Aktas Z; Ada B; Bagirova F; Baran I; Ersoy Y; Esen S; Guven TG; Hopman J; Hosoglu S; Koksal F; Parlak E; Yalcin AN; Yilmaz G; Voss A; Melchers W
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1463-8. PubMed ID: 27259712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study.
    Wang X; Qiao F; Yu R; Gao Y; Zong Z
    BMC Microbiol; 2013 Oct; 13():234. PubMed ID: 24144168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
    Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.
    Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodríguez-Baños M; Hernández-Gómez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV
    Microb Drug Resist; 2018; 24(1):48-54. PubMed ID: 28570118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.
    Ruan Z; Chen Y; Jiang Y; Zhou H; Zhou Z; Fu Y; Wang H; Wang Y; Yu Y
    Int J Antimicrob Agents; 2013 Oct; 42(4):322-8. PubMed ID: 23988720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.
    Huang L; Sun L; Yan Y
    J Microbiol; 2013 Feb; 51(1):113-7. PubMed ID: 23456719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
    Lu PL; Doumith M; Livermore DM; Chen TP; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):641-7. PubMed ID: 19182237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of bla
    Ning NZ; Liu X; Bao CM; Chen SM; Cui EB; Zhang JL; Huang J; Chen FH; Li T; Qu F; Wang H
    BMC Infect Dis; 2017 Jan; 17(1):14. PubMed ID: 28056839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
    Gogou V; Pournaras S; Giannouli M; Voulgari E; Piperaki ET; Zarrilli R; Tsakris A
    J Antimicrob Chemother; 2011 Dec; 66(12):2767-72. PubMed ID: 21933784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carbapenem consumption patterns on the molecular epidemiology and carbapenem resistance of Acinetobacter baumannii.
    Mózes J; Ebrahimi F; Gorácz O; Miszti C; Kardos G
    J Med Microbiol; 2014 Dec; 63(Pt 12):1654-1662. PubMed ID: 25261064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
    Endo S; Yano H; Hirakata Y; Arai K; Kanamori H; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Kaku M
    J Antimicrob Chemother; 2012 Jul; 67(7):1623-6. PubMed ID: 22447879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
    Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endemic carbapenem-nonsusceptible
    Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
    Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.